GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinopep Allsino Bio Pharmaceutical Co Ltd (SHSE:688076) » Definitions » EBITDA Margin %

Sinopep Allsino Bio Pharmaceutical Co (SHSE:688076) EBITDA Margin % : 19.53% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Sinopep Allsino Bio Pharmaceutical Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Sinopep Allsino Bio Pharmaceutical Co's EBITDA for the three months ended in Dec. 2023 was ¥63 Mil. Sinopep Allsino Bio Pharmaceutical Co's Revenue for the three months ended in Dec. 2023 was ¥324 Mil. Therefore, Sinopep Allsino Bio Pharmaceutical Co's EBITDA margin for the quarter that ended in Dec. 2023 was 19.53%.


Sinopep Allsino Bio Pharmaceutical Co EBITDA Margin % Historical Data

The historical data trend for Sinopep Allsino Bio Pharmaceutical Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinopep Allsino Bio Pharmaceutical Co EBITDA Margin % Chart

Sinopep Allsino Bio Pharmaceutical Co Annual Data
Trend Dec13 Dec14 Dec15 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.51 40.38 33.64 35.68 31.42

Sinopep Allsino Bio Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.21 12.94 14.53 23.00 19.53

Competitive Comparison of Sinopep Allsino Bio Pharmaceutical Co's EBITDA Margin %

For the Biotechnology subindustry, Sinopep Allsino Bio Pharmaceutical Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinopep Allsino Bio Pharmaceutical Co's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sinopep Allsino Bio Pharmaceutical Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Sinopep Allsino Bio Pharmaceutical Co's EBITDA Margin % falls into.



Sinopep Allsino Bio Pharmaceutical Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Sinopep Allsino Bio Pharmaceutical Co's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=324.763/1033.548
=31.42 %

Sinopep Allsino Bio Pharmaceutical Co's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=63.304/324.082
=19.53 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinopep Allsino Bio Pharmaceutical Co  (SHSE:688076) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Sinopep Allsino Bio Pharmaceutical Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Sinopep Allsino Bio Pharmaceutical Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinopep Allsino Bio Pharmaceutical Co (SHSE:688076) Business Description

Traded in Other Exchanges
N/A
Address
No. 28, Linpu Road, Economic and Technological Development Zone, Jiangsu Province, Lianyungang, CHN, 222069
Sinopep Allsino Bio Pharmaceutical Co Ltd is a market-oriented, research and development and innovation-driven biomedical enterprise focusing on the research, development, production and sales of peptide drugs and small molecule chemical drugs.

Sinopep Allsino Bio Pharmaceutical Co (SHSE:688076) Headlines

No Headlines